Cargando…

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

Mycobacteroides abscessus is an opportunistic pathogen in people with structural lung conditions such as bronchiectasis, chronic obstructive pulmonary disease, and cystic fibrosis. Pulmonary M. abscessus infection causes progressive symptomatic and functional decline as well as diminished lung funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rimal, Binayak, Nicklas, Danielle A., Panthi, Chandra M., Lippincott, Christopher K., Belz, Daniel C., Ignatius, Elisa H., Deck, Daniel H., Serio, Alisa W., Lamichhane, Gyanu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117123/ https://www.ncbi.nlm.nih.gov/pubmed/36912629 http://dx.doi.org/10.1128/msphere.00665-22

Ejemplares similares

Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
por: Nicklas, Danielle A., et al.
Publicado: (2022)

A mouse model of pulmonary Mycobacteroides abscessus infection
por: Maggioncalda, Emily C., et al.
Publicado: (2020)

Development of a penem antibiotic against Mycobacteroides abscessus
por: Batchelder, Hunter R., et al.
Publicado: (2020)

Glby, Encoded by MAB_3167c, Is Required for In Vivo Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity
por: Galanis, Christos, et al.
Publicado: (2022)

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren
por: Rimal, Binayak, et al.
Publicado: (2022)

Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus
por: Ng, Hien Fuh, et al.
Publicado: (2022)

Tracheobronchopathia Osteochondroplastica Complicated with Mycobacteroides abscessus Pulmonary Disease
por: Yoshida, Seiji, et al.
Publicado: (2021)

Mycobacteroides abscessus infection in a patient with tetralogy of Fallot
por: Akaba, Tomohiro, et al.
Publicado: (2023)

New Mycobacteroides abscessus subsp. massiliense strains with recombinant hsp65 gene laterally transferred from Mycobacteroides abscessus subsp. abscessus: Potential for misidentification of M. abscessus strains with the hsp65-based method
por: Kim, Byoung-Jun, et al.
Publicado: (2019)

The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex
por: Takei, Satomi, et al.
Publicado: (2020)

Host-Pathogen Interactions Operative during Mycobacteroides abscessus Infection
por: Park, Eun-Jin, et al.
Publicado: (2021)

Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2021)

Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massiliense
por: Oka, Keisuke, et al.
Publicado: (2021)

Evaluation of Anti-Mycobacterial Compounds in a Silkworm Infection Model with Mycobacteroides abscessus
por: Hosoda, Kanji, et al.
Publicado: (2020)

The resistomes of Mycobacteroides abscessus complex and their possible acquisition from horizontal gene transfer
por: Chong, Shay Lee, et al.
Publicado: (2022)

Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages
por: Jahanbakhsh, S, et al.
Publicado: (2023)

Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
por: Dar, Hamza Arshad, et al.
Publicado: (2021)

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)

MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus
por: Kim, Hyeon Ji, et al.
Publicado: (2021)

Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
por: Pearson, Jeffrey C, et al.
Publicado: (2020)

803. Overcoming β-Lactam Resistance in Mycobacterium abscessus
por: Story-Roller, Elizabeth, et al.
Publicado: (2018)

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
por: Bax, Hannelore I, et al.
Publicado: (2019)

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
por: Morrisette, Taylor, et al.
Publicado: (2021)

Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
por: Siddiqa, Ayesha, et al.
Publicado: (2023)

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023)

Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections
por: Mingora, Christina M, et al.
Publicado: (2023)

Ohmyungsamycin promotes M1-like inflammatory responses to enhance host defence against Mycobacteroides abscessus infections
por: Jeon, Sang Min, et al.
Publicado: (2022)

Correction to: Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections
Publicado: (2023)

Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections”
por: Srivastava, Shashikant, et al.
Publicado: (2023)

Safety and tolerability of long-term use of omadacycline in the treatment of Mycobacterium abscessus infections
por: Srivastava, Shashikant, et al.
Publicado: (2023)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

1208. Omadacycline In Vitro Activity Against Bacillus Anthracis
por: Serio, Alisa W, et al.
Publicado: (2021)

Peptidoglycan compositional analysis of Mycobacterium smegmatis using high-resolution LC–MS
por: Rimal, Binayak, et al.
Publicado: (2022)

Rapid and Accurate Differentiation of Mycobacteroides abscessus Complex Species by Liquid Chromatography-Ultra-High-Resolution Orbitrap™ Mass Spectrometry
por: Bajaj, Amol O., et al.
Publicado: (2022)

Cutaneous Mycobacteroides chelonae Infection
por: Ishikane, Masahiro, et al.
Publicado: (2020)

Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence
por: Garey, Kevin W., et al.
Publicado: (2022)

Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use
por: Rizzo, Ashley R., et al.
Publicado: (2022)

Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
por: Story-Roller, Elizabeth, et al.
Publicado: (2018)

1202. Subinhibitory Concentrations of Omadacycline Inhibit Staphylococcus aureus Hemolytic Activity in Vitro
por: Serio, Alisa W, et al.
Publicado: (2020)

Sub-growth-inhibitory concentrations of omadacycline inhibit Staphylococcus aureus haemolytic activity in vitro
por: Serio, Alisa W, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rn3v55jl7drcf1h8t9k27hg0d